JAK Inhibitors

查看全部
Product Name JAK1 JAK2 JAK3 Tyk2 JAK Purity
(1R)-AZD-1480 97.62%
(2R,5S)-Ritlecitinib 99.77%
(3R,4S)-Tofacitinib 99.74%
(3S,4R)-Tofacitinib 99.80%
(3S,4S)-Tofacitinib 99.28%
(E/Z)-AG490 99.71%
(E/Z)-Zotiraciclib 99.70%
(E/Z)-Zotiraciclib citrate 99.83%
(E/Z)-Zotiraciclib hydrochloride 99.90%
(R)-9b 99.51%
(R)-α7 nAchR-JAK2-STAT3 agonist 1 99.59%
(R,R)-VVD-118313 99.34%
(Rac)-TUL01101
(S)-Lomedeucitinib 99.09%
(Z)-LFM-A13 99.80%
Pentagalloylglucose 99.57%
1,2,3,4-Tetrahydro Staurosporin
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide 99.80%
2-NP 99.55%
25-Deacetylcucurbitacin A
Leucrose 98.53%
5TTU
6-Demethoxytangeretin 99.37%
ABBV-712 99.94%
Abrocitinib 99.26%
AC-430
AC-430 hydrobromide 99.70%
AG490 99.86%
AH057
AJI-100
AJI-214
AMG-47a 99.19%
AMPK-IN-5
anti-TNBC agent-7
Antitumor agent-123
AS2553627
AT9283 99.67%
AT9283 lactic acid
Atinvicitinib 98.62%
Atiprimod
Atiprimod dimaleate
Atiprimod hydrochloride
Atopaxar 99.87%
Atopaxar hydrobromide
Atopaxar hydrochloride
AUH-6-96
Axltide
AZ-3 98.05%
AZ960 97.08%
AZD-1480 99.74%
Bayer-18
BD750 99.02%
Benzene hexabromide 98.0%
BI-1622 98.02%
Blovacitinib 99.71%
BMS-066 99.09%
BMS-911543 98.23%
BMS-986202 99.29%
BPC 157 99.74%
BPC 157 acetate 99.78%
BRD4-IN-41
Brepocitinib 99.97%
Brepocitinib P-Tosylate 99.99%
Brevilin A 99.86%
Broussonin E 98.11%
Butyzamide 99.83%
Butyzamide
BVB808
Cadefrecitinib 99.81%
Calenduloside E 99.07%
CAY10526 99.12%
CEE321
Cenacitinib 98.08%
CEP-33779 99.12%
Cerdulatinib 99.06%
Cerdulatinib hydrochloride 98.96%
Cernuumolide J
CHZ868 98.69%
Coumermycin A1 99.86%
CP-352664
CP-690550A
CS12192
CT-1 99.90%
Cyclanoline chloride 96.27%
DCZ3301 99.73%
Debio 0617B
Decernotinib 99.91%
DEL1187-126-28-16
DEL1187-126-5-80
Demethylasterriquinone B1 98.10%
Deucravacitinib 99.93%
Deucravacitinib analog 1
Deucravacitinib hydrochloride
Deucravacitinib-13C,d3
Dimethyl biphenyl-4,4'-dicarboxylate 99.85%
DPP
DPPY
DTP3 98.45%
Dual Cathepsin L/JAK-IN-1 98.47%
EC-70124
EGFR-IN-178
Envudeucitinibum 99.56%
EP009
FAK-IN-22
Fedratinib 99.83%
Fedratinib hydrochloride hydrate 99.92%
Fedratinib-d9
Filgotinib 99.77%
Filgotinib maleate 99.88%
Filgotinib-d4
FLLL32 99.41%
Flonoltinib 99.48%
Flonoltinib monomaleate
Flonoltinib sulfate
Flonoltinib TFA 98.04%
FLT3/JAK2/BRD4 ligand-1
FM-381 98.08%
FM-479 99.2%
Fosifidancitinib
Frevecitinib 99.42%
G5-7 98.45%
Gamma-glutamylcysteine ammonium
Gandotinib 99.86%
GDC-4379 98.23%
GDC-9918
GLPG0634 analog 98.07%
Glucocorticoid receptor/IL-6-IN-1
GMB-475 98.69%
Golidocitinib 99.54%
Golidocitinib (Standard)
GS-829845 99.19%
GSK2646264 99.74%
Gusacitinib 99.63%
Gusacitinib hydrochloride
Gusacitinib-d4
HAT-SIL-TG-1&AT
HD-2a
HDAC/JAK/BRD4-IN-1
HG-7-85-01 98.14%
Hispidin 99.85%
iBFAR2 97.24%
Icariside I 98.76%
Ifidancitinib 98.01%
iJak-381 99.86%
Ilginatinib 99.81%
Ilginatinib hydrochloride 98.92%
Ilginatinib maleate 99.33%
Ilunocitinib 98.24%
INCB16562
IRAK4 modulator-2 99.86%
Iridin 99.72%
Isocryptotanshinone 98%
Itacitinib 99.97%
Itacitinib adipate 99.18%
Itacnosertib 99.06%
Itacnosertib hydrochloride 99.43%
Ivarmacitinib 99.62%
Ivarmacitinib sulfate
Izencitinib 99.47%
JAK 3i 99.81%
JAK kinase-IN-1
JAK-2/3-IN-1
JAK-2/3-IN-2
JAK-2/3-IN-3
JAK-IN-1 98.39%
JAK-IN-10 99.72%
JAK-IN-11 98.62%
JAK-IN-14 99.15%
JAK-IN-15
JAK-IN-17
JAK-IN-18
JAK-IN-19
JAK-IN-20 99.63%
JAK-IN-21 99.72%
JAK-IN-23 98.88%
JAK-IN-24 99.27%
JAK-IN-26 98.00%
JAK-IN-27
JAK-IN-28
JAK-IN-29
JAK-IN-3 98.92%
JAK-IN-30
JAK-IN-31
JAK-IN-32 96.18%
JAK-IN-33
JAK-IN-34
JAK-IN-35 99.30%
JAK-IN-36
JAK-IN-37
JAK-IN-38
JAK-IN-39
JAK-IN-4
JAK-IN-40
JAK-IN-41
JAK-IN-5
JAK-IN-5 hydrochloride 99.52%
JAK-STAT-IN-1
JAK/HDAC-IN-1 98.63%
JAK/HDAC-IN-2
JAK/HDAC-IN-3
JAK/HDAC-IN-4
JAK1 Human Pre-designed siRNA Set A
Jak1 Rat Pre-designed siRNA Set A
JAK1 S729C Recombinant Human Active Protein Kinase
JAK1(JH1) Recombinant Human Active Protein Kinase
JAK1-IN-10
JAK1-IN-11 98.27%
JAK1-IN-12
JAK1-IN-13 98.65%
JAK1-IN-14
JAK1-IN-16
JAK1-IN-17
JAK1-IN-18
JAK1-IN-19
JAK1-IN-20
JAK1-IN-4 99.26%
JAK1-IN-8 95.0%
JAK1-IN-9
JAK1/2 ligand 1 99.91%
JAK1/2-IN-1 98.36%
JAK1/2-IN-2
JAK1/2-IN-3
JAK1/3-IN-1
JAK1/CDK7-IN-1
JAK1/STAT3-IN-1
JAK1/TYK2-IN-1
JAK1/TYK2-IN-3
JAK1/TYK2-IN-4
JAK1/TYK2-IN-5
JAK2 Human Pre-designed siRNA Set A
JAK2 JH2 binder-1 95.40%
JAK2 JH2 Tracer 98.03%
Jak2 Mouse Pre-designed siRNA Set A
Jak2 Rat Pre-designed siRNA Set A
JAK2(JH1/JH2) Recombinant Human Active Protein Kinase
JAK2-IN-1
JAK2-IN-10 97.97%
JAK2-IN-11 98.03%
JAK2-IN-12
JAK2-IN-13
JAK2-IN-14
JAK2-IN-15
JAK2-IN-16
JAK2-IN-17
JAK2-IN-18
JAK2-IN-19
JAK2-IN-20
JAK2-IN-21
JAK2-IN-4
JAK2-IN-5
JAK2-IN-6 97.07%
JAK2-IN-7 98.31%
JAK2-IN-9
JAK2/FLT3-IN-3
JAK2/STAT3-IN-2
JAK2/TYK2-IN-1 99.94%
JAK3 covalent inhibitor-1
JAK3 covalent inhibitor-2
JAK3 Human Pre-designed siRNA Set A
Jak3 Mouse Pre-designed siRNA Set A
Jak3 Rat Pre-designed siRNA Set A
JAK3(JH1) Recombinant Human Active Protein Kinase
JAK3-IN-1 99.31%
JAK3-IN-11
JAK3-IN-12
JAK3-IN-14 99.32%
JAK3-IN-15
JAK3-IN-16
JAK3-IN-17
JAK3-IN-18
JAK3-IN-19
JAK3-IN-20
JAK3-IN-6 99.48%
JAK3-IN-7
JAK3-IN-9
JAK3/BTK-IN-1
JAK3/BTK-IN-2
JAK3/BTK-IN-3
JAK3/BTK-IN-4
JAK3/BTK-IN-5
JAK3/BTK-IN-6
JAK3/BTK-IN-7
Jak3tide
JANEX-1 99.63%
JANEX-1 hydrochloride
JI6
JNK-IN-17
JNN-5
K882
LCC-12 formate 99.90%
Lepzacitinib 99.30%
LFM-A13 99.65%
Liensinine perchlorate 99.67%
lirucitinib 98.72%
LNK01004
Lomedeucitinib 99.75%
Londamocitinib 99.79%
Lorpucitinib 99.95%
LRRK2-IN-8
LRRK2/NUAK1/TYK2-IN-1
LS-104
M351-0056 99.48%
Mal-PEG4-NPV-PABC-DMEDA-tofacitinib
Methionyl-methionine
Methyl 6-(1-(4-methoxybenzyl)-1H-pyrazol-4-yl)-4-oxo-4,5-dihydropyrazolo[1,5-a]pyrazine-2-carboxylate 98.01%
Milpecitinib
MJ04 98.08%
MLS-2384 free base
MMT3-72
MMT3-72-M2
Mocravimod 98.39%
Mocravimod hydrochloride 99.99%
Modzatinib
Momelotinib 98.73%
Momelotinib mesylate
Momelotinib sulfate 98.45%
Momelotinib-d4 dihydrochloride hydrate
MPT0B098
MRC-G-001
MS-1020
MTP
Mulberrofuran G 97.86%
N-(3-Aminopropyl)cyclohexylamine 98.80%
Nezulcitinib
Nimucitinib 99.27%
NMS-P953
Nomelcitinib
NSC 33994
NSC 42834 96.85%
NSC114792
NUAK1-IN-3
NVP-BSK805 99.30%
NVP-BSK805 dihydrochloride 99.04%
NVP-BSK805 trihydrochloride
NVP-BVB808
Oclacitinib 99.03%
Officinalisinin I 99.80%
oJak-989
ON044580 99.11%
Osunprotafib 99.38%
Ovalicin
Pacritinib 99.88%
Pacritinib citrate 99.68%
Pacritinib hydrochloride
Pacritinib-d4 98.42%
Paeoniflorin-6′-O-benzene sulfonate
Patiromer 95.0%
Peficitinib hydrobromide
Pentadecanoic acid 99.92%
PF-00956980
PF-06263276 98.26%
PF-1367550
PHI-501
Physalin A 99.63%
PI3K/Akt/mTOR-IN-7
PJ27
pJAK2(1001-1013) 99.89%
Povorcitinib 99.00%
Povorcitinib phosphate 98.82%
Povorcitinib-d6
PRN-371
PROTAC FLT3/JAK2/BRD4 Degrader-1
PROTAC JAK1 degrader 1 99.97%
PROTAC JAK1/2 degrader-1 99.47%
PROTAC JAK2 degrader-1
PROTAC SKP2 Degrader-1 99.91%
PROTAC TYK2 degrader-1 99.46%
PROTAC TYK2 degrader-2 99.50%
PTPN2-IN-2
PTPN2/1-IN-4
Pumecitinib 99.81%
Quecitinib 99.56%
R-348 choline
RAI-20 98.66%
RGB-286638 99.67%
RGB-286638 free base 98.09%
Ritlecitinib 99.63%
Ritlecitinib malonate
Ritlecitinib tosylate 99.65%
RO495 98.59%
RO8191 98.80%
S6K1-IN-1 99.71%
SAR-20347 97.27%
SB1578
SC99 98.90%
SD-1008 99.10%
SD-1029 88.8%
SG3-179
SHP2 inhibitor LY6
SIRT5-IN-10
SJ1008030
SJ1008030 formic 98.91%
SJ1008030 TFA 98.12%
SJ10542 99.32%
SJ988497 99.03%
Socrodeucitinib
Soficitinib
STAT3-IN-18
STAT3-IN-46
STS-E412 98.56%
SYK/JAK-IN-1
TCJL37 99.89%
TCS 21311 99.49%
Ten01
TG101209 98.13%
Thi-DPPY
TK4b
TK4g
Tkip 95.16%
TM-233
Tofacitinib Prodrug-1
TP1L
Tubulin/JAK2-IN-1 99.14%
Tubulosine
TYD-68 99.54%
TYK2 activator-1
TYK2 JH2-IN-1-d3
TYK2 ligand 1
TYK2 ligand 2
TYK2 ligand 3
TYK2 ligand 4
TYK2(JH1) Recombinant Human Active Protein Kinase
Tyk2(JH1/JH2) Recombinant Human Active Protein Kinase
TYK2(JH2) Recombinant Human Active Protein Kinase
Tyk2-IN-10
TYK2-IN-11
TYK2-IN-12 98.81%
Tyk2-IN-15
Tyk2-IN-16
Tyk2-IN-17
Tyk2-IN-18
Tyk2-IN-18-d3
Tyk2-IN-18-d5
Tyk2-IN-19 98.62%
TyK2-IN-2 99.05%
Tyk2-IN-20
TyK2-IN-21-d3
Tyk2-IN-22
Tyk2-IN-22-d3
Tyk2-IN-23
Tyk2-IN-3
Tyk2-IN-5 99.35%
Tyk2-IN-7 99.58%
Tyk2-IN-8 98.04%
Tyk2-IN-9
Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9)
UCB9386 99.89%
UF010 99.83%
UNC1062 98.92%
VDR agonist 4
Voderdeucitinib
VVD-118313 99.47%
WCY-8-67
WCY-8-67 TFA 99.40%
WHI-P154 98.77%
WHI-P97 99.16%
WP-1034
WP1066 99.53%
WP1193
WWQ-03-012 98.04%
WWQ-131
WYE-151650
XL019 99.65%
YLIU-4-105-1 99.39%
YSY01A
YYSW001
Zasocitinib 99.24%
Zingiberen newsaponin 99.68%
ZM 449829 99.73%
ZM39923
ZM39923 hydrochloride 99.84%
Zotiraciclib 99.88%
Zotiraciclib hydrochloride
ZT55 99.51%
α7 nAchR-JAK2-STAT3 agonist 1 98.51%
Gamma-glutamylcysteine 98.53%
Gamma-glutamylcysteine TFA 96.68%
Notoginsenoside R2 99.80%
Upadacitinib 99.98%
Upadacitinib-d5
Upadacitinib tartrate tetrahydrate
Ginsenoside Rk1 99.37%
Curculigoside 99.82%
Peficitinib 99.38%
Peficitinib-d3
Clifutinib 99.59%
Ponicidin 99.93%
Protosappanin A 99.95%
Dehydrocrenatidine 98.0%
Icaritin 99.06%
Desmethoxyyangonin 99.00%
Pyridone 6 98.20%
Mollugin 99.79%
Oclacitinib monomaleate 99.87%
Anumigilimab 98.43%
Microhelenin C 99.55%
Jolkinolide B 99.65%
Jolkinolide B (Standard)
Baricitinib-d3 99.0%
Baricitinib-d5 98.98%
Baricitinib 99.93%
Isotoosendanin 99.51%
Tofacitinib 99.94%
Tofacitinib-13C3 99.77%
Tofacitinib-13C3,15N 99.57%
Tofacitinib metabolite-1 99.59%
Tropisetron 99.93%
Tropisetron-d5
Lestaurtinib 99.66%
Tofacitinib-d3 citrate 99.53%
Tofacitinib citrate 99.94%
Phlorizin 99.93%
Phlorizin dihydrate 98.0%
Delphinidin chloride 98.0%
Swertiamarin 99.03%
Cycloartenyl ferulate 99.15%
Reticuline 98.89%
Pulchinenoside E2 99.28%
Atractylenolide I 99.98%
Peficitinib hydrochloride
Baricitinib phosphate 99.97%
Solcitinib 99.51%
(Rac)-Ruxolitinib-d9 97.18%
Graveoline 99.93%
Momelotinib dihydrochloride
Liensinine 99.97%
Liensinine Diperchlorate 99.96%
Cucurbitacin I 99.60%
Bufothionine
Crocin 99.30%
Raspberry ketone glucoside 99.52%
Telocinobufagin 99.50%
Delgocitinib 99.61%
Delgocitinib ethanolate
Wilforine 99.47%
Radotinib 99.19%
Radotinib-d6
Radotinib dihydrochloride
Fezakinumab 99.9%
Lentinan
Ruxolitinib (S enantiomer) 99.64%
Deuruxolitinib 99.18%
Ruxolitinib-d9
Ruxolitinib 99.90%
Ruxolitinib sulfate
Ruxolitinib phosphate 99.97%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础